Twist Bioscience Corporation (TWST) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to Twist Biosciences' 2026 Second Quarter Financial Results Conference Call. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question, you will need to press star 1-1. In the interest of time, we ask that you please limit yourself to one question. Also note, this call is being recorded. I would like to turn the call over to Angela Bidding, SVP of Corporate Affairs. Please go ahead. Thank you, Operator. Good morning, everyone. I would like to thank you for joining us for TWIST Bioscience's conference call to review our fiscal 2026 second quarter financial results and business progress. We issued our financial results press release before the market, and it is available at our website at www.twistbioscience.com. With me on the call today are Dr. Emily LaPruce, CEO and co-founder of TWIST, Adam Loponis, CFO of TWIST, and Dr. Patrick Finn, President and CEO of TWIST. Today we will discuss our business progress, financial and operational performance, as well as growth opportunities. We will then open a call for questions. We ask that you limit your questions to only one and then re-queue as a courtesy to others on the call. This call is being recorded. The audio portion will be archived in the investor section of our website and will be available for two weeks. During today's presentation, we will make forward-looking statements within the meaning of the U.S. federal securities laws. Forward-looking statements generally relate to future events or future financial or operating performance. Our expectations and beliefs regarding these matters may not materialize, and actual results and financial periods are subject to risks and uncertainties that could cause actual result...